Short communication · 18 May 2021
Byline
M. Ezeibe
Articles whose byline reads M. Ezeibe, printed as Maduike C O Ezeibe, Maduike C. O. Ezeibe, Maduike Ezeibe and Maduike C.O. Ezeibe. Different authors can share a byline.
- Articles
- 10
- Latest year
- 2021
Articles
Newest first. Showing 1–10 of 10 articles.
Conference abstract · 3 Sep 2018
Antiviral mechanisms of the Medicinal synthetic Aluminum-magnesium silicate {Al4 (SiO4)3 + 3Mg2SiO4 → 2Al2 Mg3 (SiO4)3}, against immune deficiency (“incurable”) infections (HIV, HBV and HCV)
Conference abstract · 27 Jul 2017
Responses of HIV-positive and HIV/AIDS patients to treatment with the Medicinal synthetic Aluminum-magnesium silicate{Al4(SiO4)3 + 3Mg2SiO4 → 2Al2Mg3(SiO4)3}.
Conference abstract · 28 Nov 2016
Medicinal synthetic aluminum-magnesium silicate [Al4(SiO4)3+3Mg2SiO4→2Al2Mg3(SiO4)3] effective treatment for HIV/AIDS
Conference abstract · 28 Nov 2016
Clinical trial of Medicinal synthetic Aluminum-magnesium silicate (Antivirt®) on CD4-Lymphocytes counts and viral loads of HIV/AIDS patients
Conference abstract · 28 Nov 2016
Medicinal synthetic aluminum-magnesium silicate [Al4(SiO4)3+3Mg2SiO4→2Al2Mg3(SiO4)3] effective treatment for HIV/AIDS
Conference abstract · 2 May 2016
Stabilizing antimicrobials with the Medicinal synthetic Aluminum – magnesium silicate, to enhance their efficacy
Conference abstract · 7 Dec 2015
Medicinal synthetic Aluminum-magnesium silicate {Al4(SiO4)3 + 3Mg2SiO4 → 2Al2Mg3(SiO4)3}: A highly active anti-retroviral medicine
Conference abstract · 7 Dec 2015
Medicinal synthetic Aluminum-magnesium silicate {Al4(SiO4)3 + 3Mg2SiO4 → 2Al2Mg3(SiO4)3} – A highly active anti-retroviral medicine.
Conference abstract

